Bio-Techne
TECH
#1420
Rank
NZ$20.50 B
Marketcap
$129.24
Share price
4.51%
Change (1 day)
7.63%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Bio-Techne (TECH) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : NZ$1.02 B

According to Bio-Techne's latest financial reports the company's total liabilities are NZ$1.02 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Bio-Techne - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-06-30NZ$1.09 B15.43%
2022-06-30NZ$0.94 B-4.15%
2021-06-30NZ$0.99 B-1.22%
2020-06-30NZ$1.00 B-6.23%
2019-06-30NZ$1.06 B40.85%
2018-06-30NZ$0.75 B-8.67%
2017-06-30NZ$0.83 B135.96%
2016-06-30NZ$0.35 B11.93%
2015-06-30NZ$0.31 B310.96%
2014-06-30NZ$76.59 M46.23%
2013-06-30NZ$52.37 M-6.35%
2012-06-30NZ$55.92 M45.93%
2011-06-30NZ$38.32 M55.92%
2010-06-30NZ$24.57 M3.01%
2009-06-30NZ$23.86 M-10.31%
2008-06-30NZ$26.6 M18.95%
2007-06-30NZ$22.36 M-55.09%
2006-06-30NZ$49.8 M27.12%
2005-06-30NZ$39.17 M-11.87%
2004-06-30NZ$44.45 M-2.91%
2003-06-30NZ$45.79 M-29.86%
2002-06-30NZ$65.28 M-29.9%
2001-06-30NZ$93.13 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
NZ$82.37 B 7,925.14%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$4.70 B 358.20%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$48.02 B 4,579.09%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$46.31 B 4,412.16%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$3.52 B 243.20%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
NZ$168.66 B 16,332.16%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$39.5 M-96.15%๐Ÿ‡บ๐Ÿ‡ธ USA